![PubReading [74] - Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts - R. Marfella, G. Paolisso et al.](https://pbcdn.aoneroom.com/image/2025/10/01/7e6046e0a35206382805a998ee97f6e9.jpg)
![PubReading [74] - Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts - R. Marfella, G. Paolisso et al.](https://pbcdn.aoneroom.com/image/2025/10/01/7e6046e0a35206382805a998ee97f6e9.jpg)
PubReading [74] - Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts - R. Marfella, G. Paolisso et al.
1 tracks • 0 plays • 0 favorites
PubReading [74] - Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts - R. Marfella, G. Paolisso et al.
Mégane pro
0:0028:18
Success & Inspiration
Episodes
1
PubReading [74] - Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts - R. Marfella, G. Paolisso et al.
Mégane pro